FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2610479233> ?p ?o ?g. }

• W2610479233 endingPage "1279" @default.
• W2610479233 startingPage "1270" @default.
• W2610479233 abstract "Since 2004, when the first synthetic glycoconjugate vaccine against the pneumonia and meningitis causing bacterium Haemophilus influenza type b (Hib) approved for human use in Cuba was reported, 34 million doses of the synthetic vaccine have been already distributed in several countries under the commercial name of Quimi-Hib. However, despite the success of this product, no other synthetic glycoconjugate vaccine has been licensed in the following 13 years. As well as avoiding the need to handle pathogens, synthetic glycoconjugates offer clear advantages in terms of product characterization and the possibility to understand the parameters influencing immunogenicity. Nevertheless, large scale application of synthetic sugars has been perceived as challenging because of manufacturing costs and process complexity compared to natural polysaccharides. Chemoenzymatic approaches, one-pot protocols, and automated solid-phase synthesis are rendering carbohydrate production considerably more attractive for industrialization. Here we identify three areas where chemical approaches can advance this progress: (i) chemical or enzymatic methods enabling the delivery of the minimal polysaccharide portion responsible for an effective immune response; (ii) site-selective chemical or enzymatic conjugation strategies for the exploration of the conjugation point in immune responses against carbohydrate-based vaccines, and the consistent preparation of more homogeneous products; (iii) multicomponent constructs targeting receptors responsible for immune response modulation in order to control its quality and magnitude. We discuss how synthesis of bacterial oligosaccharides is useful toward understanding the polysaccharide portion responsible for immunogenicity, and for developing robust and consistent alternatives to natural heterogeneous polysaccharides. The synthesis of sugar analogues can lead to the identification of hydrolytically more stable versions of oligosaccharide antigens. The study of bacterial polysaccharide biosynthesis aids the development of in vitro hazard-free oligosaccharide production. Novel site-selective conjugation methods contribute toward deciphering the role of conjugation sites in the immunogenicity of glycoconjugates and prove to be particularly useful when glycans are conjugated to protein serving as carrier and antigen. The orthogonal incorporation of two different carbohydrate haptens enables the reduction of vaccine components. Finally, coordinated conjugation of glycans and small molecule immunopotentiators supports simplification of vaccine formulation and localization of adjuvant. Synergistic advancement of these areas, combined with competitive manufacturing processes, will contribute to a better understanding of the features guiding the immunological activity of glycoconjugates and, ultimately, to the design of improved, safer vaccines." @default.
• W2610479233 created "2017-05-12" @default.
• W2610479233 creator A5024994464 @default.
• W2610479233 date "2017-05-02" @default.
• W2610479233 modified "2023-09-25" @default.
• W2610479233 title "Advancing Homogeneous Antimicrobial Glycoconjugate Vaccines" @default.
• W2610479233 cites W1963668760 @default.
• W2610479233 cites W1974085861 @default.
• W2610479233 cites W1981494855 @default.
• W2610479233 cites W1982659689 @default.
• W2610479233 cites W1983004361 @default.
• W2610479233 cites W1984325070 @default.
• W2610479233 cites W1996401266 @default.
• W2610479233 cites W1997099073 @default.
• W2610479233 cites W1997190724 @default.
• W2610479233 cites W2007855505 @default.
• W2610479233 cites W2011504601 @default.
• W2610479233 cites W2016152759 @default.
• W2610479233 cites W2020918172 @default.
• W2610479233 cites W2026607286 @default.
• W2610479233 cites W2028546109 @default.
• W2610479233 cites W2029522688 @default.
• W2610479233 cites W2034092386 @default.
• W2610479233 cites W2045465609 @default.
• W2610479233 cites W2050057463 @default.
• W2610479233 cites W2051800685 @default.
• W2610479233 cites W2060987490 @default.
• W2610479233 cites W2071866439 @default.
• W2610479233 cites W2078703243 @default.
• W2610479233 cites W2090499893 @default.
• W2610479233 cites W2096704107 @default.
• W2610479233 cites W2105664303 @default.
• W2610479233 cites W2112765785 @default.
• W2610479233 cites W2117364171 @default.
• W2610479233 cites W2118575726 @default.
• W2610479233 cites W2129406104 @default.
• W2610479233 cites W2135044072 @default.
• W2610479233 cites W2135792697 @default.
• W2610479233 cites W2138865528 @default.
• W2610479233 cites W2140019337 @default.
• W2610479233 cites W2143873194 @default.
• W2610479233 cites W2148413579 @default.
• W2610479233 cites W2160713580 @default.
• W2610479233 cites W2161248261 @default.
• W2610479233 cites W2161793112 @default.
• W2610479233 cites W2165168809 @default.
• W2610479233 cites W2169253475 @default.
• W2610479233 cites W2252977645 @default.
• W2610479233 cites W2319886162 @default.
• W2610479233 cites W2322637803 @default.
• W2610479233 cites W2323883449 @default.
• W2610479233 cites W2325516935 @default.
• W2610479233 cites W2335116282 @default.
• W2610479233 cites W2341958038 @default.
• W2610479233 cites W2344245530 @default.
• W2610479233 cites W2466894347 @default.
• W2610479233 cites W2473619978 @default.
• W2610479233 cites W2518529034 @default.
• W2610479233 cites W2551650437 @default.
• W2610479233 cites W2560101058 @default.
• W2610479233 cites W2590315902 @default.
• W2610479233 cites W2592211706 @default.
• W2610479233 cites W2608423787 @default.
• W2610479233 doi "https://doi.org/10.1021/acs.accounts.7b00106" @default.
• W2610479233 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28463499" @default.
• W2610479233 hasPublicationYear "2017" @default.
• W2610479233 type Work @default.
• W2610479233 sameAs 2610479233 @default.
• W2610479233 citedByCount "48" @default.
• W2610479233 countsByYear W26104792332017 @default.
• W2610479233 countsByYear W26104792332018 @default.
• W2610479233 countsByYear W26104792332019 @default.
• W2610479233 countsByYear W26104792332020 @default.
• W2610479233 countsByYear W26104792332021 @default.
• W2610479233 countsByYear W26104792332022 @default.
• W2610479233 countsByYear W26104792332023 @default.
• W2610479233 crossrefType "journal-article" @default.
• W2610479233 hasAuthorship W2610479233A5024994464 @default.
• W2610479233 hasConcept C13426554 @default.
• W2610479233 hasConcept C185592680 @default.
• W2610479233 hasConcept C203014093 @default.
• W2610479233 hasConcept C2780868878 @default.
• W2610479233 hasConcept C55493867 @default.
• W2610479233 hasConcept C70721500 @default.
• W2610479233 hasConcept C86803240 @default.
• W2610479233 hasConcept C8891405 @default.
• W2610479233 hasConceptScore W2610479233C13426554 @default.
• W2610479233 hasConceptScore W2610479233C185592680 @default.
• W2610479233 hasConceptScore W2610479233C203014093 @default.
• W2610479233 hasConceptScore W2610479233C2780868878 @default.
• W2610479233 hasConceptScore W2610479233C55493867 @default.
• W2610479233 hasConceptScore W2610479233C70721500 @default.
• W2610479233 hasConceptScore W2610479233C86803240 @default.
• W2610479233 hasConceptScore W2610479233C8891405 @default.
• W2610479233 hasIssue "5" @default.
• W2610479233 hasLocation W26104792331 @default.
• W2610479233 hasLocation W26104792332 @default.
• W2610479233 hasOpenAccess W2610479233 @default.

• next